Just last week, a 36-year-old Brazilian possibly became the first person to experience long-term remission from HIV., researchers at the Federal University of São Paulo announced.
This is the type of health news that fits Brazil’s long-standing place near the top of scientific research in the developing world – and even worldwide. How can a country known for innovative health policies be making headlines for its spiraling Covid-19 crisis, second only to the United States in number of cases and deaths?
While the answer is nuanced, one of the reasons is the politicization of health policy and governance. And it stands to show how quickly progress can be unmade.
